Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 21, 2018

View Archived Issues

GeNeuro monoclonal antibody GNbAC-1 receives U.S. orphan designation for CIDP

BX-795 as a promising new antiviral agent against HSV-1 infection of the eye

Vical starts phase II trial of VL-2397 for treatment of invasive aspergillosis

Allergan exercises third option for DARPin product candidates

Umeclidinium has clinical effects in phase II study in palmar hyperhidrosis

FDA accepts Acorda Therapeutics' NDA for Inbrija

INSERM and collaborators patent antibodies targeting tumor associated macrophages

Xenon Pharmaceuticals initiates clinical testing of antiepileptic drug candidate XEN-901

Novel apoptosis regulator Bcl-2 and/or Bcl-xl inhibitors identified at the University of Michigan

Pivotal phase III PALISADE study of AR-101 meets primary endpoint

University of Hong Kong presents new platinum complexes

Sunshine Lake Pharma identifies new farnesoid X receptor agonists

Max-Planck-Gesellschaft describes novel influenza type b vaccines

Cullinan Oncology, MAB Discovery announce agreement to develop novel antibody therapeutics

Mirikizumab improves quality of life of patients with moderate to severe psoriasis

Imugene reports preclinical in vivo data for arginine modulator

Cedars-Sinai and Emulate pioneer Patient-on-a-Chip program

FDA denies PTC Therapeutics' appeal regarding ataluren NDA, but suggests possible path forward

3D Signatures announces topline results for Telo-HL test for Hodgkin's lymphoma

Genexine to use PharmaJet devices in clinical studies

Soleno Therapeutics completes end-of-phase II meeting for diazoxide choline controlled-release

Celgene licenses technology from Amunix

Alcyone Lifesciences' hydrocephalus business now new company

Safety data presented for tivozanib combined with nivolumab in patients with mRCC

Tetraphase and Everest Medicines sign licensing agreement for eravacycline in China

DNA origami-designed nanorobot delivers thrombin specifically to tumors

Tell us what you think about TRDN

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...